SEC Form 4 · accession 0000884731-16-000066
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer Lyn Herron
Officer — Exec V.P. Chief Comm'l Officer
Period of report
May 31, 2016
Accepted (ET)
Jun 1, 2016 · 4:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $8.85 | May 31, 2016 | A | 300,000 | A | May 31, 2017 | May 31, 2026 | Common Stock | 300,000 | 300,000 | D |
Explanation of responses
- F1The options vest as to 25% of the award (75,000 shares) on May 31, 2017, and as to 6.25% of the award (18,750 shares) every three months thereafter for 36 months.